BMC Cancer (Feb 2007)

A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors

  • Candelaria Myrna,
  • Gallardo-Rincón Dolores,
  • Arce Claudia,
  • Cetina Lucely,
  • Aguilar-Ponce Jose,
  • Arrieta Oscar,
  • Serrano Alberto,
  • Perez-Plasencia Carlos,
  • Gonzalez-Fierro Aurora,
  • de la Cruz-Hernandez Erik,
  • Revilla-Vazquez Alma,
  • Chavez-Blanco Alma,
  • Trejo-Becerril Catalina,
  • Perez-Cardenas Enrique,
  • Taja-Chayeb Lucia,
  • Camargo Maria F,
  • Robles Elizabeth,
  • Dueñas-Gonzalez Alfonso

DOI
https://doi.org/10.1186/1471-2407-7-S1-A27
Journal volume & issue
Vol. 7, no. Suppl 1
p. A27

Abstract

Read online

No abstracts available.